$5.05
0.12.02%
In chiusura: Nov 26, 4:00 PM EST
$5.07
0.020.40%
After hour: 5:35 PM EST
Comments
Loading...
Stime degli utili, EPS e fatturato
Puma Biotechnology segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
feb 26
Stima EPS
$0.220
Stima dei ricavi trimestrali
$68.60M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$212.00M
Analizza lo storico degli utili di Puma Biotechnology utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PBYI | Puma Biotechnology | $0.43 | $0.22 | — | — | $59.10M | $68.60M | — | — | 02/26/2026 | |
PBYI | Puma Biotechnology | $0.45 | $0.08 | $0.21 | 162.50% | $80.50M | $49.95M | $54.50M | 9.11% | 11/06/2025 | |
PBYI | Puma Biotechnology | -$0.05 | $0.07 | $0.15 | 114.29% | $47.10M | $51.27M | $49.20M | -4.04% | 08/07/2025 | |
PBYI | Puma Biotechnology | -$0.05 | $0.03 | $0.10 | 233.33% | $43.80M | $44.55M | $46.00M | 3.25% | 05/08/2025 | |
PBYI | Puma Biotechnology | $0.31 | $0.14 | $0.43 | 207.14% | $72.20M | $52.50M | $59.10M | 12.57% | 02/27/2025 | |
PBYI | Puma Biotechnology | $0.17 | $0.35 | $0.45 | 28.57% | $56.10M | $70.65M | $80.50M | 13.94% | 11/07/2024 | |
PBYI | Puma Biotechnology | $0.10 | -$0.10 | -$0.05 | 50.00% | $54.60M | $47.30M | $47.10M | -0.42% | 08/01/2024 | |
PBYI | Puma Biotechnology | $0.09 | -$0.22 | -$0.05 | 77.27% | $52.80M | $41.05M | $43.80M | 6.70% | 05/02/2024 | |
PBYI | Puma Biotechnology | -$0.07 | $0.30 | $0.31 | 3.33% | $65.70M | $73.55M | $72.20M | -1.84% | 02/29/2024 | |
PBYI | Puma Biotechnology | $0.05 | $0.08 | $0.17 | 112.50% | $57.10M | $57.95M | $56.10M | -3.19% | 11/02/2023 | |
PBYI | Puma Biotechnology | $0.28 | $0.07 | $0.10 | 42.86% | $59.50M | $51.37M | $54.60M | 6.29% | 08/03/2023 | |
PBYI | Puma Biotechnology | -$0.01 | -$0.07 | $0.09 | 228.57% | $45.70M | $49.63M | $52.80M | 6.39% | 05/04/2023 | |
PBYI | Puma Biotechnology | $0.21 | $0.01 | -$0.07 | -800.00% | $55.40M | $57.06M | $65.70M | 15.14% | 03/02/2023 | |
PBYI | Puma Biotechnology | -$0.99 | -$0.05 | $0.05 | 200.00% | $46.20M | $50.13M | $57.10M | 13.90% | 11/03/2022 | |
PBYI | Puma Biotechnology | $0.32 | — | $0.28 | — | $53.40M | $51.97M | $59.50M | 14.49% | 08/04/2022 | |
PBYI | Puma Biotechnology | $0.55 | -$0.17 | -$0.01 | 94.12% | $98.20M | $45.07M | $45.70M | 1.40% | 05/05/2022 | |
PBYI | Puma Biotechnology | -$0.14 | — | $0.21 | — | $52.60M | $47.17M | $55.40M | 17.45% | 03/03/2022 | |
PBYI | Puma Biotechnology | -$0.60 | -$0.31 | -$0.99 | -219.35% | $50.80M | $53.31M | $46.20M | -13.34% | 11/04/2021 | |
PBYI | Puma Biotechnology | $0.35 | -$0.34 | -$0.13 | 61.76% | $70.60M | $51.60M | $53.40M | 3.49% | 08/05/2021 | |
PBYI | Puma Biotechnology | -$0.43 | $0.09 | $0.55 | 511.11% | $51.20M | $71.47M | $98.20M | 37.40% | 05/06/2021 | |
PBYI | Puma Biotechnology | -$0.29 | -$0.29 | -$0.14 | 51.72% | $62.90M | $52.79M | $52.60M | -0.36% | 02/25/2021 |
Puma Biotechnology (PBYI) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0.21 | $0.08 | 162.5 % |
| Q2 | 2025-08-07 | $0.15 | $0.07 | 114.3 % |
| Q1 | 2025-05-08 | $0.10 | $0.03 | 233.3 % |
| Q4 | 2025-02-27 | $0.43 | $0.14 | 207.1 % |
Puma Biotechnology (PBYI) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $54.50M | $49.95M | 9.11 % |
| Q2 | 2025-08-07 | $49.20M | $51.27M | -4.04 % |
| Q1 | 2025-05-08 | $46.00M | $44.55M | 3.25 % |
| Q4 | 2025-02-27 | $59.10M | $52.50M | 12.6 % |
FAQ
Quando Puma Biotechnology (NASDAQ:PBYI) riporterà gli utili?
Si prevede che Puma Biotechnology (PBYI) fornisca risultati il febbraio 26, 2026. Gli ultimi risultati sono stati pubblicati il novembre 6, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Puma Biotechnology (NASDAQ:PBYI)?
L'EPS effettivo era $0.21, che superato la stima di $0.08.
Quali sono state le entrate di Puma Biotechnology (NASDAQ:PBYI)?
Le entrate effettive sono state $54.5M, che superato la stima di $49.9M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.